금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Six Key Issues to Watch at NATO’s Ankara Summit
NATO leaders are meeting in the Turkish capital, Ankara, for the alliance’s annual summit on July 7-...
India Could Return To Iranian Crude If U.S. Extends Sanctions Waiver
Indian state-held refiners are considering buying Iranian crude oil if the United States extends the...
Chip Rally Collapses, Dragging Down Nasdaq. Dow, S&P 500 Also Dropping.
The Nasdaq tumbled on Tuesday to continue a turbulent time for chip stocks. The tech-heavy index fel...
AHR, CURB, JAN REITs top the list of 10 least attractively valued U.S. mid-cap stocks
Target dividend could slip below prior payout, snapping 57-year growth streak
Piper says 'buy the hype' and 'buy the news' on Take-Two Interactive's GTA 6
Iridium Communications, Telephone and Data Systems lead list of least attractively valued mid-cap communications services stocks
Taking care of your family shouldn’t wreck your retirement
Unpaid family work is costing caregivers $1,000 a month. Here is how Congress wants to help them catch up.
These 10 small-cap REITs carry the least attractive valuation grades: DHC leads the screen
Meet the Low-Cost Vanguard ETF With 30% Invested in Nvidia, Broadcom, Micron, AMD, and Intel That's on Track to Beat the S&P 500 for the Fourth Consecutive Year
The semiconductor industry has been the driving force behind the tech sector's sustained outperformance.
Sector Update: Energy Stocks Rise Tuesday Afternoon
Energy stocks were higher Tuesday afternoon, with the NYSE Energy Sector Index rising 1.3% and the S
These 10 small-cap energy stocks carry the market's least attractive valuations
Stock Market Today: Dow Leads As Nasdaq Struggles; Celestica Rallies Again (Live Coverage)
Stock Market Today: The Dow Jones index climbs Tuesday with U.S.-Iran talks ongoing. A copper stock breaks out while Xometry slides.
Why Virgin Galactic’s stock is having its worst day ever, after a record-smashing 7-day run
The space-tourism company made a move to pay off some debt, but investors aren’t happy that it will issue new shares to do so.
Draft FDA guidance could be a boon for gene therapy developers